AMO (Advanced Medical Optics) sells notes for $250m to finance IntraLase buy:
This article was originally published in Clinica
Advanced Medical Optics (AMO) has priced its private offering of senior subordinated notes at $250m. The notes were offered only to qualified institutional buyers and non-US foreign investors. The transaction is linked to and will close concurrently with the Santa Ana, California eye care technology firm's $808m purchase of laser eye surgery company IntraLase (see Clinica No 1239, p 1). AMO also intends to access a new senior credit facility to fund the acquisition.
You may also be interested in...
The FDA’s OPQ touts approval of sixth and seventh continuously manufactured drugs and quicker delivery of inspection results in latest annual report.
No device-related warning letters were released by the US FDA the week of 19 February.
Complex generics and value added medicines share common challenges on harmonization of regulation, lack of incentives and clarity of guidelines, heard delegates to Medicines for Europe’s Regulatory & Scientific Affairs conference.